Skip to main content
Top
Literature
2.
go back to reference Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling JH, Kessels A, Prins MH, Stobberingh EE, Verbon A (2011) Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 37:110–117. doi:10.1007/s00134-010-2002-6 PubMedCrossRef Oudhuis GJ, Bergmans DC, Dormans T, Zwaveling JH, Kessels A, Prins MH, Stobberingh EE, Verbon A (2011) Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 37:110–117. doi:10.​1007/​s00134-010-2002-6 PubMedCrossRef
3.
go back to reference Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123–127PubMedCrossRef Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, Bengmark S, Neuhaus P (2002) Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74:123–127PubMedCrossRef
4.
go back to reference Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–659PubMedCrossRef Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG (2008) Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371:651–659PubMedCrossRef
5.
go back to reference Siempos II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38:954–962PubMedCrossRef Siempos II, Ntaidou TK, Falagas ME (2010) Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 38:954–962PubMedCrossRef
6.
go back to reference Silvestri L, van Saene HK, Gregori D, Agostini S, Francescon M, Taylor N (2010) Probiotics to prevent ventilator-associated pneumonia: no robust evidence from randomized controlled trials. Crit Care Med 38:1616–1617 (author reply 1617)PubMedCrossRef Silvestri L, van Saene HK, Gregori D, Agostini S, Francescon M, Taylor N (2010) Probiotics to prevent ventilator-associated pneumonia: no robust evidence from randomized controlled trials. Crit Care Med 38:1616–1617 (author reply 1617)PubMedCrossRef
7.
go back to reference de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360:20–31PubMedCrossRef de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, van der Hoeven JG, Pickkers P, Bogaers-Hofman D, van der Meer NJ, Bernards AT, Kuijper EJ, Joore JC, Leverstein-van Hall MA, Bindels AJ, Jansz AR, Wesselink RM, de Jongh BM, Dennesen PJ, van Asselt GJ, te Velde LF, Frenay IH, Kaasjager K, Bosch FH, van Iterson M, Thijsen SF, Kluge GH, Pauw W, de Vries JW, Kaan JA, Arends JP, Aarts LP, Sturm PD, Harinck HI, Voss A, Uijtendaal EV, Blok HE, Thieme Groen ES, Pouw ME, Kalkman CJ, Bonten MJ (2009) Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 360:20–31PubMedCrossRef
8.
go back to reference van Saene HK, Taylor N, Damjanovic V, Sarginson RE (2008) Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr Drug Targets 9:419–421PubMedCrossRef van Saene HK, Taylor N, Damjanovic V, Sarginson RE (2008) Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr Drug Targets 9:419–421PubMedCrossRef
9.
go back to reference Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG (2005) Prevention of infectious complications in surgical patients: potential role of probiotics. Dig Surg 22:234–244PubMedCrossRef Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG (2005) Prevention of infectious complications in surgical patients: potential role of probiotics. Dig Surg 22:234–244PubMedCrossRef
Metadata
Title
Reply to Petros et al.: Gut overgrowth harms the critically ill
Authors
Guy J. Oudhuis
Dennis C. Bergmans
Ellen E. Stobberingh
Annelies Verbon
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 9/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2288-z

Other articles of this Issue 9/2011

Intensive Care Medicine 9/2011 Go to the issue